Dan T. Stinchcomb

City:

Enumclaw, Washington

Country:

United States

Published Applications:

Last publication date:

2023-06-15

Top Assignees for applications by Dan T. Stinchcomb

The entities that hold a legal rights for patent applications filed by inventor Stinchcomb Dan T.:

Takeda Vaccines, Inc. 5 Cambridge, MA United States
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 2 Atlanta, GA United States
IGM Biosciences, Inc. 2 Mountain View, CA United States
THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT 1 Atlanta, GA United States
THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY 1 ATLANTA, GA United States
INVIRAGEN, INC. 1 Fort Collins, CO United States

Recent patent applications by Stinchcomb Dan T.

Dan T. Stinchcomb from Enumclaw, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-06-15

US20230181682A1

Human necessities

Compositions and methods for dengue virus chimeric constructions in vaccines

#2 | 2022-03-03

US20220062375A1

Human necessities

Compositions and methods for dengue virus chimeric constructions in vaccines

#3 | 2020-12-03

US20200377577A1

Chemistry; metallurgy

Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof

#4 | 2020-02-27

US20200061151A1

Human necessities

Compositions and Methods for Dengue Virus Chimeric Constructs in Vaccines

#5 | 2019-05-09

US20190134182A1

Human necessities

Compositions and methods for live, attenuated alphavirus formulations

#6 | 2018-09-06

US20180251737A1

Chemistry; metallurgy

COMPOSITIONS, METHODS AND USES FOR INDUCING VIRAL GROWTH

#7 | 2018-05-03

US20180118816A1

Chemistry; metallurgy

Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof

#8 | 2018-01-11

US20180008691A1

Human necessities

COMPOSITIONS AND METHODS FOR RAPID IMMUNIZATION AGAINST DENGUE VIRUS

#9 | 2017-10-12

US20170290884A1

Human necessities

Compositions and methods for dengue virus chimeric constructs in vaccines

#10 | 2014-09-18

US20140271715A1

Human necessities

Compositions and methods for live, attenuated alphavirus formulations

InventorID:

2007085 ⎘